Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery

Hypertension

Volumn 61, Issue 2, 2013, Pages 450-456

  Chinushi, Masaomi ^a   Izumi, Daisuke ^b   Iijima, Kenichi ^b   Suzuki, Katsuya ^a   Furushima, Hiroshi ^b   Saitoh, Osamu ^a   Furuta, Yui ^a   Aizawa, Yoshifusa ^b   Iwafuchi, Mitsuya ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

electrical stimulation; hypertension; radiofrequency ablation; renal artery

Indexed keywords

CATECHOLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CATHETER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROSTIMULATION; HEART RATE; HEART RATE VARIABILITY; KIDNEY ARTERY; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SENSORY NERVE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CATECHOLAMINES; CATHETER ABLATION; DOGS; ELECTRIC STIMULATION; HEART RATE; RENAL ARTERY;

EID: 84873059975     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00095     Document Type: Article

References (27)

1. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
2. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
3. Krum H, Barman N, Schlaich M, et al. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911-917.
4. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic- nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932-934.
5. Chinushi M, Restivo M, Caref EB, El-Sherif N. Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long-QT syndrome: tridimensional analysis of the kinetics of cardiac repolarization. Circ Res. 1998;83:614-628. (Pubitemid 28427745)
6. Verma A, Saliba WI, Lakkireddy D, Burkhardt JD, Cummings JE, Wazni OM, Belden WA, Thal S, Schweikert RA, Martin DO, Tchou PJ, Natale A. Vagal responses induced by endocardial left atrial autonomic ganglion stimulation before and after pulmonary vein antrum isolation for atrial fibrillation. Heart Rhythm. 2007;4:1177-1182. (Pubitemid 47324115)
7. Pokushalov E, Romanov A, Shugayev P, Artyomenko S, Shirokova N, Turov A, Katritsis DG. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2009;6:1257-1264.
8. Sawada Y, Ohtomo N, Tanaka Y, Tanaka G, Yamakoshi K, Terachi S, Shimamoto K, Nakagawa M, Satoh S, Kuroda S, Iimura O. New technique for time series analysis combining the maximum entropy method and non-linear least squares method: its value in heart rate variability analysis. Med Biol Eng Comput. 1997;35:318-322. (Pubitemid 27373142)
9. Murasato Y, Hirakawa H, Harada Y, Nakamura T, Hayashida Y. Effects of systemic hypoxia on R-R interval and blood pressure variabilities in conscious rats. Am J Physiol. 1998;275(3 pt 2):H797-H804.
10. Sugiura H, Chinushi M, Komura S, Hirono T, Aizawa Y. Heart rate variability is a useful parameter for evaluation of anticholinergic effect associated with inducibility of atrial fibrillation. Pacing Clin Electrophysiol. 2005;28:1208-1214. (Pubitemid 43947901)
11. Krum H, Sobotka P, Mahfoud F, Böhm M, Esler M, Schlaich M. Devicebased antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation. 2011;123:209-215.
12. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension. 2003;41(3 pt 2):621-624.
13. DiBona GF. Physiology in perspective: the wisdom of the body-neural control of the kidney. Am J Physiol Regul Integr Comp Physiol. 2005;289:R633-R641.
14. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad- Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918. (Pubitemid 23006966)
15. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25(4 pt 2):878-882.
16. Kumagai H, Oshima N, Matsuura T, Iigaya K, Imai M, Onimaru H, Sakata K, Osaka M, Onami T, Takimoto C, Kamayachi T, Itoh H, Saruta T. Importance of rostral ventrolateral medulla neurons in determining efferent sympathetic nerve activity and blood pressure. Hypertens Res. 2012;35:132-141.
17. Wyss JM, Carlson SH. The role of the central nervous system in hypertension. Curr Hypertens Rep. 1999;1:246-253.
18. Esler M. The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol. 2010;108:227-237.
19. Kopp UC, Cicha MZ, Smith LA, Mulder J, Hökfelt T. Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve fibers. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1561-R1572. (Pubitemid 47535774)
20. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol. 2010;298:R245-R253.
21. Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens. 2002;15:717-724. (Pubitemid 34804278)
22. Shweta A, Denton KM, Kett MM, Bertram JF, Lambert GW, Anderson WP. Paradoxical structural effects in the unilaterally denervated spontaneously hypertensive rat kidney. J Hypertens. 2005;23:851-859. (Pubitemid 40523285)
23. Nakagawa H, Yamanashi WS, Pitha JV, Arruda M, Wang X, Ohtomo K, Beckman KJ, McClelland JH, Lazzara R, Jackman WM. Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation. Circulation. 1995;91:2264-2273.
24. Wittkampf FH, Nakagawa H. RF catheter ablation: lessons on lesions. Pacing Clin Electrophysiol. 2006;29:1285-1297. (Pubitemid 44707114)
25. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba PL, Mancia G. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia. 2005;48:1359-1365. (Pubitemid 41186102)
26. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974-1979. (Pubitemid 35176304)
27. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163-1170.